TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
CADL

Candel Therapeutics Inc

Healthcare · Biotechnology

11.30$ -4.7% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CADL
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
98.5% 91.8% 95.2% 91.6% 89.3% 97.1% 95.6%
11.3% 91.6% 92.6% 89.2% 86.0% 96.1% 95.6%
98.2% 91.6% 92.6% 89.2% 86.0% 96.1% 95.6%
0.9% 7.3% 4.3% 7.0% – – –
117.5% 161.5% 28.1% 39.2% 69.1% 37.9% 58.5%
3.1% 12.3% 6.0% 7.2% 34.4% 35.1% 7.2%
– 1.2% – 0.6% 22.8% 9.8% 0.4%
0.5% 2.4% 1.8% 0.5% 1.0% 0.2% 0.9%
0.9% 1.3% 0.6% 26.6% 30.1% 2.4% 37.6%
-17.5% -61.5% 71.9% 60.8% 30.9% 62.1% 41.5%
-57.7% -115.4% -90.0% -126.2% -332.6% -179.9% -184.0%
40.8% 48.9% 21.2% 36.7% 70.2% 29.6% 42.3%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?